Eli Lilly and Company (LLY) on Tuesday announced the launch of an artificial intelligence and machine learning platform called Lilly TuneLab. The platform provides biotech companies access to drug ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback